Review Article

Cytokine Profile in Chronic Periodontitis Patients with and without Obesity: A Systematic Review and Meta-Analysis

Table 1

General characteristics of included studies.

Author et al., yearStudy design; setting; countryNumber of patientsMean age/age range in yearsGender (M/F)Periodontitis diagnostic criteriaGCF sample siteSample characteristics:
sample type; collection tool; and storage temperature

Duzagac et al. [17], 2015Prospective non-RCT; university clinic; Turkey45Group 1: 40.66 (28–52)
Group 2: 41.06 (28–51)
Group 3: 39.66 (30–52)
19/26PD ≥ 4 mm in ≥30% sites, BOP in ≥50% of sites, CAL > 2 mm in ≥20% sites, and radiographic evidence of bone lossNAGCF; paper strips; −80°C

Gonçalves et al. [19], 2015Prospective non-RCT; university clinic; Brazil40Group 1: 50.0 (±4.5)
Group 2: 48.5 (±9.3)
21/19PD and CAL ≥ 4 mm in >30% teethTwo noncontiguous deep sites (PD and CAL ≥ 5 mm with BoP)GCF; paper strips; −80°C

Pradeep et al. [20], 2015Cross-sectional; university clinic; India40Group 1: 32.5 (25–40)
Group 2: 30.9 (25–40)
Group 3: 31.0 (25–40)
Group 4: 31.4 (25–40)
20/20PD ≥ 5 mm, GI > 1, and CAL ≥ 3 mm with clinical signs of inflammationNAGCF; paper strips; −70°C

Pradeep et al. [21], 2016Cross-sectional; university clinic; India40Group 1: 33.8 (±3.9)
Group 2: 35.1 (±3.9)
Group 3: 35.6 (±3.7)
Group 4: 34.3 (±4.06)
20/20PD ≥ 5 mm, GI > 1, and CAL ≥ 3 mm with clinical signs of inflammationNAGCF; paper strips; −70°C

Öngöz Dede et al. [22], 2016Prospective non-RCT; university clinic; Turkey90Group 1: 47.13 (34–60)
Group 2: 38.47 (26–51)
Group 3: 35.73 (25–55)
Group 4: 31.53 (25–53)
Group 5: 41.33 (25–50)
Group 6: 29.60 (25–33)
43/47GI ≥ 2, PD and CAL ≥ 5 mm, and bone loss affecting >30% teeth≥5 mm CAL, ≥6 mm PD, and ≥30% bone lossGCF; paper strips; −40°C

Patel and Raju [23], 2014Cross-sectional; university clinic; India90Group 1: NA (23–54)
Group 2: NA (23–54)
Group 3: NA (23–54)
45/45GI > 1, PD ≥ 5 mm, CAL ≥ 3 mm, and evidence of radiographic bone lossCAL ≥ 3 mmGCF; micropipettes; 1 L; −70°C

Fadel et al. [24], 2014Cross-sectional; obesity clinic; Sweden55Group 1: 15.0 (±1.0)
Group 2: 16.0 (±2.0)
29/26NANAGCF; paper strips; −80°C

Zimmermann et al. [6], 2013Cross-sectional; University clinic; Brazil78Group 1: 51.5 (±7.6)
Group 2: 47.8 (±7.7)
Group 3: 43.2 (±7.4)
Group 4: 42.9 (±7.2)
21/57≥30% sites with PD and CAL ≥ 4 mm and ≥4 noncontagious teeth with ≥1 site with PD and CAL ≥ 5 mmTwo noncontiguous deep sites (PD and CAL ≥ 5 mm with BoP)GCF; paper strips; 4 L; −80°C

Pradeep et al. [25], 2013Cross-sectional; university clinic; India40Group 1: 31.6 (25–45)
Group 2: 32.8 (25–45)
Group 3: 33.2 (25–45)
Group 4: 31.4 (25–45)
20/20PD ≥ 5 mm, GI > 1, and CAL ≥ 3 mm with clinical signs of inflammationNAGCF; paper strips; −70°C

Pradeep et al. [26], 2012Cross-sectional; university clinic; India40Group 1: 36.8 (25–45)
Group 2: 35.2 (25–45)
Group 3: 35.2 (25–45)
Group 4: 32.4 (25–45)
20/20PD ≥ 5 mm, GI > 1, and CAL ≥ 3 mm with clinical signs of inflammationNAGCF; paper strips; −70°C

Modéer et al. [16], 2011Cross-sectional; university clinic; Sweden104Group 1: 14.5 (11.0–17.9)
Group 2: 14.5 (10.9–17.1)
58/46≥1 sites with PD > 4 mm and alveolar bone loss ≥ 2 mmNAGCF; paper strips; −70°C

RCT: randomized clinical trial, M/F: male to female ratio, GCF: gingival crevicular fluid, PD: pocket depth, CAL: clinical attachment loss, BoP: bleeding on probing, GI: gingival index, and NA: not available.